Rosacea Market Size, Share, Trends, Growth Outlook

The global Rosacea market size is estimated to be $2.3 Billion in 2023, at a CAGR of 5.47% between 2023 and 2030.

The increasing prevalence of the condition and growing awareness and affordability driven by the launch of new drug candidates and a strong pipeline are poised to drive the market.

 

Rosacea Market Analysis

Growing awareness about rosacea, increasing prevalence of the condition, changing lifestyles coupled with awareness programs, and the absence of treatment for rosacea are encouraging companies to invest significantly in R&D to develop products to gain from the huge unmet demand. Companies like Sol-Gel Technologies, Biowest Therapeutics, Maruho Co., Ltd, Amgen, Alfasigma, Biomemtix, Timber Pharmaceuticals, and others are focusing on constantly assessing diverse mechanisms of action to identify potential treatment options.

Rosacea is a chronic, inflammatory, and vascular disorder affecting the face. Onset is usually after age 30 and typically begins as flushing and subtle redness on the cheeks, nose, chin, or forehead. The characteristic skin lesions (erythema, visible blood vessels, papules, and pustules) appear on the face, and with the progression of the disease, the redness becomes more persistent, blood vessels become visible and pimples often appear. In addition, burning, stinging, dry skin, plaques, and skin thickening are other symptoms observed in the condition.

Rosacea is one of the most common conditions treated by dermatologists but the etiology of the condition is unknown. A family history of the disease is a risk factor, as is the very light skin phototype (Celtic skin type). The condition may be triggered by consumption of alcohol, spicy food, and changes in weather, exposure to sun or hot showers. Stinging, burning, sensitivity of the skin and inability to tolerate cosmetics are also common in rosacea. The condition has a strong impact on quality of life and can be associated with depressive symptoms.

 

Market Dynamics

Market Trend- Combination topical therapy continues to gain traction

While single-agent topical therapy is among the leading treatment option preferred for rosacea patients, an increasing trend towards the use of combination topical therapy is being observed. Metronidazole and azelaic acid are among the most prescribed combination for the condition. A combination of topical and oral medication such as Ivermectin and oral doxycycline is also being assessed.

According to the National Rosacea Society, fixed centrofacial erythema with periodic intensification, and phymatous changes remain the primary phenotypes while papules and pustules, flushing, telangiectasia, and ocular manifestations can also co-occur with the primary symptoms. Further, secondary signs and symptoms such as burning or stinging sensations, facial edema, and a dry appearance of central facial skin can be observed among patients.

As Rosacea is an evolving condition, physicians consider all clinical signs and symptoms of rosacea observed in an individual patient, identifying those signs and symptoms that change over time, and accordingly suggest the most suitable combination therapy applicable to target all rosacea symptoms.

 

Market Driver- Rosacea Has Strong Unmet Demand

Rosacea presents significant unmet demand potential. As the approved drugs do not treat the condition but instead treat the symptoms and signs, there exists huge unmet market demand. Further, a high rate of treatment discontinuation coupled with side effects of long-term usage restrict market size growth.

Pharmaceutical companies and institutes are investing in developing drugs that have minimal side effects and more efficacy such as extended-release and microencapsulation technology

 

Market Opportunity- Unknown etiology poses challenges for new product development

The etiology of Rosacea remains undefined, posing challenges for treatment options. It is one of the most common subtypes of dermatology conditions. The trigger factors also vary significantly, and the progression of the disease in patients varies significantly from patient to patient. The underlying cause of the disease and its progression is largely unknown.

 

Market Segmentation

The global Rosacea Market is segmented into Drug Types, Routes of Administration, and Countries.

The topical mode of administration dominated the industry during the forecast period

Topical mode of administration remains the preferred choice for both physicians and patients due to the limited side effects associated with the medicines. Further, the majority of incidences of rosacea are Erythematotelangiectatic Rosacea and Papulopustular Rosacea, symptoms associated with these conditions are often treated with topical gels and foams.

Topically administered drugs such as metronidazole and clindamycin control the disease's progress through anti-inflammatory effects similar to oral medications. Further, the foray of new drug candidates in classes such as Vasoconstrictors and Azelic acid supports the growth of the market.

Over the forecast period to 2030, a large volume of topical drug candidates is in the pipeline, predominantly in Phase 3 and Phase 2, which will further drive the market growth outlook.

 

By Region, North America accounts for the highest market size for the period 2023 to 2030

North America is the largest region in the global Rosacea market, accounting for 71% market share. The launch of diverse products, well-established marketing, high awareness, and affordability among the population, and increasing incidences of cases are the main factors driving the industry. The majority of global companies aim to strengthen their presence across the region through the launch of new products to gain huge market opportunities in the industry. The market is characterized by significant growth of Mergers and Acquisition activities.

The US is the largest market for rosacea treatment worldwide, driven by a large patient population, availability of treatment options, and high affordability. Galderma continues to dominate the market structure with a rapid growth rate compared to competitors. However, the planned launch of new generics is likely to lower the demand for prescription products.

 

Segmentation

By Drug Type

• Alpha agonist
• Antibiotics
• Azelaic acid
• Others

 

By Route of Administration

• Oral
• Topical

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Key Players

Leading companies profiled in the study include-

• Galderma
• Allergan Plc.
• Bayer Schering AG
• Leo Pharma Inc.
• Bausch Health Companies Inc.
• Foamix Pharmaceuticals
• Sol-Gel Technologies
• Aclaris Therapeutics
• Hovione FarmaCiencia SA
• Nestlé

 

Rosacea Market Outlook 2023

1 Market Overview

1.1 Introduction to Rosacea Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Rosacea Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Rosacea Market Companies with Area Served

4.2.2 Products Offerings Global Rosacea Market

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 Post-COVID-19 Scenario- Low Growth Case

5.1.3 Post-COVID-19 Scenario- Reference Growth Case

5.1.4 Post-COVID-19 Scenario- Low Growth Case

 

6 Global Rosacea Market Trends

6.1 Global Rosacea Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Rosacea Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Rosacea Revenue (USD Million) and CAGR (%) by Regions (2018-2030)

 

7 Global Rosacea Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Rosacea Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Rosacea Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Rosacea Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Rosacea Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Rosacea Development Regional Status and Outlook

8.1 Global Rosacea Revenue (USD Million) By Regions (2018-2022)

8.2 North America Rosacea Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Rosacea Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Rosacea Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Rosacea Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Rosacea Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Rosacea Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Rosacea Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Rosacea Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Rosacea Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Rosacea Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Rosacea Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Rosacea Revenue (USD Million) by Applications (2018-2022)

8.5 South America Rosacea Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Rosacea Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Rosacea Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Rosacea Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Rosacea Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Rosacea Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Rosacea Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Rosacea Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Rosacea Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Rosacea Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Rosacea Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Rosacea Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Rosacea Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

11 Global Rosacea Development Regional Status and Outlook Forecast

11.1 Global Rosacea Revenue (USD Million) By Regions (2023-2030)

11.2 North America Rosacea Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Rosacea Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Rosacea Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Rosacea Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Rosacea Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Rosacea Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Rosacea Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Rosacea Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Rosacea Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Rosacea Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Rosacea Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Rosacea Revenue (USD Million), by Applications (2023-2030)

11.5 South America Rosacea Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Rosacea Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Rosacea Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Rosacea Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Rosacea Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Rosacea Revenue (USD Million), by Region (2023-2030)

11.6.2 Middle East and Africa Rosacea Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Rosacea Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List Of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Rosacea Market Companies with Areas Served

Table 3 Products Offerings Global Rosacea Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Rosacea Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Rosacea Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Rosacea Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Rosacea Revenue (USD Million) By Type (2018-2022)

Table 11 Global Rosacea Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Rosacea Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Rosacea Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Rosacea Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Rosacea Market Share (%) By Regions (2018-2022)

Table 16 North America Rosacea Revenue (USD Million) By Country (2018-2022)

Table 17 North America Rosacea Revenue (USD Million) By Type (2018-2022)

Table 18 North America Rosacea Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Rosacea Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Rosacea Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Rosacea Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Rosacea Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Rosacea Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Rosacea Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Rosacea Revenue (USD Million) By Country (2018-2022)

Table 26 South America Rosacea Revenue (USD Million) By Type (2018-2022)

Table 27 South America Rosacea Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Rosacea Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Rosacea Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Rosacea Revenue (USD Million) By Applications (2018-2022)

 

Table 31 Financial Analysis

Table 32 Global Rosacea Revenue (USD Million) By Type (2023-2030)

Table 33 Global Rosacea Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Rosacea Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Rosacea Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Rosacea Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Rosacea Revenue (USD)By Country (2023-2030)

Table 38 North America Rosacea Revenue (USD Million) By Type (2023-2030)

Table 39 North America Rosacea Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Rosacea Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Rosacea Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Rosacea Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Rosacea Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Rosacea Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Rosacea Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Rosacea Revenue (USD Million) By Country (2023-2030)

Table 47 South America Rosacea Revenue (USD Million) By Type (2023-2030)

Table 48 South America Rosacea Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Rosacea Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Rosacea Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Rosacea Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Rosacea Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

 

List Of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Rosacea Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Rosacea Revenue Market Share (%) By Type (2022)

Figure 5 Global Rosacea Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Rosacea Revenue Market Share (%) By Applications (2022)

Figure 7 Global Rosacea Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Rosacea Market Share (%) By Regions (2022)

Figure 9 North America Rosacea Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Rosacea Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Rosacea Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Rosacea Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Rosacea Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Rosacea Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Rosacea Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Rosacea Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Rosacea Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Rosacea Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Rosacea Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Rosacea Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Rosacea Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Rosacea Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Rosacea Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Rosacea Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Rosacea Revenue Market Share (%) By Type (2030)

Figure 26 Global Rosacea Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Rosacea Revenue Market Share (%) By Applications (2030)

Figure 28 Global Rosacea Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Rosacea Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Rosacea Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Rosacea Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Rosacea Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Rosacea Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Rosacea Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Rosacea Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Rosacea Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Rosacea Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Rosacea Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Rosacea Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Rosacea Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Rosacea Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Rosacea Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Rosacea Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Rosacea Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches For This Report

Figure 46 Data Triangulation

 

Market Segmentation

By Drug Type

• Alpha agonist
• Antibiotics
• Azelaic acid
• Others

 

By Route of Administration

• Oral
• Topical

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)